WOOF
Petco Health & Wellness Company, Inc.
Company overview
- Market capitalization
- —
- Employees
- 29,000
- Latest publication
- 2026-09-29
About Petco Health & Wellness Company, Inc.
Petco Health and Wellness Company, Inc., operates as a pet specialty retailer, focuses on enhancing the lives of pets, pet parents, and its Petco partners in the United States, Mexico, Puerto Rico, and Chile. The company provides veterinary care, grooming, and training services; and pet care supplies and companion animals. It also offers a range of consumables, supplies, and services through its petco.com website and mobile app. In addition, the company treats whole pet, including their physical, mental, and social well-being. It offers its products under the WholeHearted, Reddy, So Phresh, and Well & Good brand names. Petco Health and Wellness Company, Inc. was founded in 1965 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-08-01 · USD | Q4 20262026-01-31 · USD | Q3 20262025-10-31 · USD | Q1 20262025-04-30 · USD | Q4 20252025-01-31 · USD | Q3 20252024-10-31 · USD | Q2 20252024-07-31 · USD | Q1 20252024-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,489,220,000USD | 1,515,128,000USD | 1,464,411,000USD | 1,493,399,000USD | 1,552,130,000USD | 1,511,437,000USD | 1,523,755,000USD | 1,529,140,000USD |
| Cost Of Revenue | 898,073,000USD | 934,358,000USD | 895,396,000USD | 923,431,000USD | 1,013,183,000USD | 985,789,000USD | 943,030,000USD | 950,480,000USD |
| Gross Profit | 591,147,000USD | 580,770,000USD | 569,015,000USD | 569,968,000USD | 538,947,000USD | 525,648,000USD | 580,725,000USD | 578,660,000USD |
| Selling General Administrative | 543,335,000USD | 548,914,000USD | 539,819,000USD | 553,609,000USD | 571,872,000USD | 571,780,000USD | 578,257,000USD | 595,442,000USD |
| Total Operating Expenses | 543,335,000USD | 548,914,000USD | 539,819,000USD | 553,609,000USD | 514,018,000USD | 515,861,999USD | 578,257,000USD | 595,442,000USD |
| Operating Income | 47,812,000USD | 31,856,000USD | 29,196,000USD | 16,359,000USD | 24,929,000USD | 9,786,000USD | 2,468,000USD | -16,782,000USD |
| Total Other Income Expense Net | -30,063,000USD | -23,130,000USD | -31,013,000USD | -27,525,000USD | -36,262,000USD | -27,316,000USD | -31,942,000USD | -34,178,000USD |
| Interest Income | 2,493,000USD | 2,223,000USD | 1,814,000USD | 1,359,000USD | 1,278,000USD | 1,346,000USD | 672,000USD | 418,000USD |
| Interest Expense | 32,556,000USD | 31,581,000USD | 32,827,000USD | 33,494,000USD | 34,111,000USD | 35,797,000USD | 36,805,000USD | 36,817,000USD |
| Income Before Tax | 17,749,000USD | 8,726,000USD | -1,817,000USD | -11,166,000USD | -11,333,000USD | -17,530,000USD | -29,474,000USD | -50,960,000USD |
| Income Tax Expense | -15,710,000USD | 11,301,000USD | -11,147,000USD | 495,000USD | 2,504,000USD | -857,000USD | -4,651,000USD | -4,477,000USD |
| Equity Method Income Loss | 5,201,000USD | — | — | — | — | — | — | — |
| Net Income | 38,660,000USD | -2,575,000USD | 9,330,000USD | -11,661,000USD | -13,837,000USD | -16,673,000USD | -24,823,000USD | -46,483,000USD |
| Net Interest Income | — | -29,358,000USD | -31,013,000USD | -32,135,000USD | -32,833,000USD | -34,451,000USD | -36,133,000USD | -36,399,000USD |
| Tax Provision | — | 11,301,000USD | -6,276,000USD | 495,000USD | 2,504,000USD | -857,000USD | -4,651,000USD | -4,477,000USD |
| Net Income From Continuing Ops | — | -2,575,000USD | 9,330,000USD | -11,661,000USD | -13,837,000USD | -16,673,000USD | -24,823,000USD | -46,483,000USD |
| Ebit | — | 31,856,000USD | 31,010,000USD | 17,718,000USD | 17,777,000USD | 14,588,000USD | 3,140,000USD | -19,029,000USD |
| Ebitda | — | 79,423,000USD | 80,827,000USD | 67,083,000USD | 68,090,000USD | 64,697,000USD | 52,858,000USD | 30,558,000USD |
| Depreciation And Amortization | — | 47,567,000USD | 49,817,000USD | 49,365,000USD | 50,313,000USD | 50,109,000USD | 49,718,000USD | 49,587,000USD |
| Reconciled Depreciation | — | 48,244,000USD | 49,817,000USD | 49,365,000USD | 50,313,000USD | 50,109,000USD | 49,718,000USD | 49,587,000USD |
| Unclassified Operating Expenses | — | — | — | — | -57,854,000USD | -55,918,001USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-01-31 · USD | FY 20252025-01-31 · USD | FY 20242024-01-31 · USD | FY 20232023-01-31 · USD | FY 20222022-01-31 · USD | FY 20212021-01-31 · USD | FY 20202020-01-31 · USD | FY 20192019-01-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,961,467,000USD | 6,116,462,000USD | 6,255,284,000USD | 6,035,967,000USD | 5,807,149,000USD | 4,920,202,000USD | 4,434,514,000USD | 4,392,173,000USD |
| Cost Of Revenue | 3,656,395,000USD | 3,792,060,000USD | 3,901,449,000USD | 3,608,860,000USD | 3,380,539,000USD | 2,813,464,000USD | 2,527,995,000USD | 2,487,334,000USD |
| Gross Profit | 2,305,072,000USD | 2,324,402,000USD | 2,353,835,000USD | 2,427,107,000USD | 2,426,610,000USD | 2,106,738,000USD | 1,906,519,000USD | 1,904,839,000USD |
| Selling General Administrative | 2,184,639,000USD | 2,152,475,000USD | 2,311,625,000USD | 2,201,548,000USD | 2,160,539,000USD | 1,912,314,000USD | 1,776,919,000USD | 1,647,487,000USD |
| Total Operating Expenses | 2,184,639,000USD | 2,317,351,000USD | 3,534,149,000USD | 2,201,548,000USD | 2,160,539,000USD | 1,912,314,000USD | 1,795,919,000USD | 1,746,387,000USD |
| Operating Income | 120,433,000USD | 7,051,000USD | -1,180,314,000USD | 225,559,000USD | 266,071,000USD | 194,424,000USD | 110,600,000USD | -214,720,000USD |
| Interest Income | 6,305,000USD | 3,714,000USD | 3,405,000USD | 1,032,000USD | 62,000USD | 653,000USD | 335,000USD | 420,000USD |
| Interest Expense | 131,199,000USD | 143,531,000USD | 150,909,000USD | 101,643,000USD | 77,397,000USD | 219,083,000USD | 253,018,000USD | 243,744,000USD |
| Net Interest Income | -124,894,000USD | -139,817,000USD | -147,504,000USD | -100,611,000USD | -77,335,000USD | -218,400,000USD | -252,683,000USD | -243,324,000USD |
| Income Before Tax | 15,332,000USD | -109,297,000USD | -1,307,823,000USD | 125,257,000USD | 213,278,000USD | -41,555,000USD | -139,642,000USD | -458,504,000USD |
| Income Tax Expense | 6,266,000USD | -7,481,000USD | -27,613,000USD | 35,347,000USD | 53,473,000USD | -3,337,000USD | -35,658,000USD | -45,840,000USD |
| Tax Provision | 6,266,000USD | -7,481,000USD | -27,613,000USD | 35,347,000USD | 53,473,000USD | -3,300,000USD | -35,658,000USD | -45,840,000USD |
| Net Income | 9,066,000USD | -101,816,000USD | -1,280,210,000USD | 90,801,000USD | 164,417,000USD | -26,483,000USD | -95,873,000USD | -413,788,000USD |
| Net Income From Continuing Ops | 9,066,000USD | -101,816,000USD | -1,280,210,000USD | 76,934,000USD | 159,805,000USD | -31,800,000USD | -103,984,000USD | -413,788,000USD |
| Ebit | 120,433,000USD | 15,565,000USD | -1,172,614,000USD | 213,924,000USD | 279,792,000USD | 177,528,000USD | 110,935,000USD | -201,657,000USD |
| Ebitda | 317,143,000USD | 7,051,000USD | -971,832,000USD | 407,752,000USD | 452,223,000USD | 352,364,000USD | 284,479,000USD | -14,660,000USD |
| Depreciation And Amortization | 196,710,000USD | -8,514,000USD | 200,782,000USD | 193,828,000USD | 172,431,000USD | 174,836,000USD | 173,544,000USD | 186,997,000USD |
| Reconciled Depreciation | 196,710,000USD | 199,727,000USD | 200,782,000USD | 193,828,000USD | 172,431,000USD | 174,836,000USD | 173,544,000USD | 186,997,000USD |
| Total Other Income Expense Net | -105,101,000USD | -116,348,000USD | -127,509,000USD | -100,302,000USD | -52,793,000USD | -235,979,000USD | -250,242,000USD | -243,784,000USD |
| Selling And Marketing Expenses | — | 156,086,000USD | — | — | — | — | — | 79,600,000USD |
| Minority Interest | — | 0USD | 0USD | -891,000USD | 4,612,000USD | -13,583,000USD | -8,330,000USD | -8,330,000USD |
| Unclassified Operating Expenses | — | — | 1,222,524,000USD | — | — | — | 19,000,000USD | 19,300,000USD |
| Non Operating Income Net Other | — | — | — | 1,341,000USD | 24,604,000USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | — | 90,801,000USD | 164,417,000USD | -26,483,000USD | -95,873,000USD | -413,788,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-08-01 · USD | Q4 20262026-01-31 · USD | Q3 20262025-10-31 · USD | Q1 20262025-04-30 · USD | Q4 20252025-01-31 · USD | Q3 20252024-10-31 · USD | Q2 20252024-07-31 · USD | Q1 20252024-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,166,650,000USD | 5,173,425,000USD | 5,205,124,000USD | 5,121,136,000USD | 5,194,430,000USD | 5,211,480,000USD | 5,276,647,000USD | 5,259,042,000USD |
| Cash And Equivalents | 293,498,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 1,053,098,000USD | 1,019,786,000USD | 1,007,400,000USD | 920,430,000USD | 973,619,000USD | 931,783,000USD | 941,893,000USD | 904,055,000USD |
| Other Current Assets | 65,190,000USD | 127,028,000USD | 109,191,000USD | 105,536,000USD | 114,109,000USD | 84,385,000USD | 94,910,000USD | 91,237,000USD |
| Other Non Current Assets | 209,668,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 3,959,723,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,166,444,000USD | 1,134,141,000USD | 1,103,460,000USD | 1,083,477,000USD | 1,139,163,000USD | 1,113,679,000USD | 1,117,851,000USD | 1,069,439,000USD |
| Other Current Liabilities | 225,908,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 77,907,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,206,927,000USD | 1,164,254,000USD | 1,157,596,000USD | 1,107,330,000USD | 1,113,630,000USD | 1,122,838,000USD | 1,131,483,000USD | 1,162,309,000USD |
| Total Equity Including Noncontrolling Interest | 1,206,927,000USD | — | — | — | — | — | — | — |
| Net Receivables | 38,386,000USD | 45,812,000USD | 42,900,000USD | 36,079,000USD | 40,425,000USD | 40,432,000USD | 47,035,000USD | 42,081,000USD |
| Inventory | 601,591,000USD | 590,210,000USD | 617,896,000USD | 645,472,000USD | 653,329,000USD | 690,291,000USD | 672,328,000USD | 681,020,000USD |
| Property Plant Equipment Net | 1,898,820,000USD | 1,944,741,000USD | 3,649,067,000USD | 2,004,485,000USD | 2,027,784,000USD | 2,068,204,000USD | 2,128,445,000USD | 2,136,104,000USD |
| Goodwill | 980,064,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 455,314,000USD | 450,552,000USD | 429,978,000USD | 473,906,000USD | 492,878,000USD | 447,673,000USD | 474,496,000USD | 464,524,000USD |
| Short Term Debt | 340,643,000USD | 324,690,000USD | 351,752,000USD | 310,423,000USD | 311,746,000USD | 345,731,000USD | 311,602,000USD | 311,669,000USD |
| Retained Earnings | -1,116,479,000USD | -1,139,993,000USD | -1,137,418,000USD | -1,160,720,000USD | -1,149,059,000USD | -1,135,221,000USD | -1,118,549,000USD | -1,093,726,000USD |
| Accumulated Other Comprehensive Income | -5,050,000USD | -8,389,000USD | -9,758,000USD | -20,477,000USD | -18,083,000USD | -13,268,000USD | -10,623,000USD | 9,008,000USD |
| Intangible Assets | — | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD |
| Total Liab | — | 4,009,171,000USD | 4,047,528,000USD | 4,013,806,000USD | 4,080,800,000USD | 4,088,642,000USD | 4,145,164,000USD | 4,096,733,000USD |
| Other Current Liab | — | 358,899,000USD | 321,730,000USD | 299,148,000USD | 261,013,000USD | 320,275,000USD | 331,753,000USD | 293,246,000USD |
| Common Stock | — | 282,000USD | 281,000USD | 279,000USD | 277,000USD | 275,000USD | 274,000USD | 271,000USD |
| Capital Stock | — | 282,000USD | 281,000USD | 279,000USD | 277,000USD | 275,000USD | 274,000USD | 271,000USD |
| Good Will | — | 980,064,000USD | 980,064,000USD | 980,064,000USD | 980,064,000USD | 980,064,000USD | 980,064,000USD | 980,064,000USD |
| Cash | — | 256,736,000USD | 237,413,000USD | 133,343,000USD | 165,756,000USD | 116,675,000USD | 127,620,000USD | 89,717,000USD |
| Cash And Short Term Investments | — | 256,736,000USD | 237,413,000USD | 133,343,000USD | 165,756,000USD | 116,675,000USD | 127,620,000USD | 89,717,000USD |
| Net Debt | — | 2,603,666,000USD | 3,767,836,999USD | 2,791,137,000USD | 2,769,734,000USD | 2,870,234,000USD | 2,864,321,000USD | 2,889,574,000USD |
| Short Long Term Debt Total | — | 2,860,402,000USD | 4,005,249,999USD | 2,924,480,000USD | 2,935,490,000USD | 2,986,909,000USD | 2,991,941,000USD | 2,979,291,000USD |
| Long Term Debt | — | 1,488,527,000USD | 1,581,950,000USD | 1,579,338,000USD | 1,578,091,000USD | 1,576,856,000USD | 1,575,630,000USD | 1,574,486,000USD |
| Property Plant Equipment Gross | — | 3,666,801,000USD | 3,649,067,000USD | 3,584,695,000USD | 3,568,261,000USD | 3,561,956,000USD | 3,575,625,000USD | 3,535,048,000USD |
| Common Stock Shares Outstanding | — | 281,236,000shares | 288,221,000shares | 277,548,000shares | 276,305,000shares | 274,495,000shares | 273,074,000shares | 269,768,000shares |
| Non Current Assets Total | — | 4,153,639,000USD | 4,197,724,000USD | 4,200,706,000USD | 4,220,811,000USD | 4,279,697,000USD | 4,334,754,000USD | 4,354,987,000USD |
| Non Current Liabilities Total | — | 2,875,030,000USD | 2,944,068,000USD | 2,930,329,000USD | 2,941,637,000USD | 2,974,963,000USD | 3,027,313,000USD | 3,027,294,000USD |
| Non Current Liabilities Other | — | 51,052,000USD | 105,693,000USD | 108,563,000USD | 49,378,000USD | 123,077,000USD | 127,400,000USD | 119,019,000USD |
| Non Currrent Assets Other | — | 203,834,000USD | -1,456,407,000USD | 191,157,000USD | 187,963,000USD | 206,429,000USD | 201,245,000USD | 213,819,000USD |
| Net Working Capital | — | -114,355,000USD | -96,060,000USD | -163,047,000USD | -165,544,000USD | -181,896,000USD | -175,958,000USD | -165,384,000USD |
| Unclassified Non Current Liabilities | — | 1,335,451,000USD | 1,256,425,000USD | 1,242,428,000USD | 1,314,168,000USD | 1,275,030,000USD | 1,324,283,000USD | 1,333,789,000USD |
| Unclassified Equity | — | 2,312,072,000USD | 2,304,210,000USD | 2,287,969,000USD | 2,280,218,000USD | 2,270,777,000USD | 2,260,107,000USD | 2,246,485,000USD |
| Short Long Term Debt | — | — | 5,102,000USD | 5,372,000USD | — | 5,294,000USD | 5,095,000USD | 3,680,000USD |
| Unclassified Non Current Assets | — | — | -1,456,407,000USD | — | — | — | — | — |
| Current Deferred Revenue | — | — | — | — | 29,564,000USD | — | -5,095,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | 43,962,000USD | — | — | — |
| Short Term Investments | — | — | — | — | — | — | 655,000USD | 3,703,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-01-31 · USD | FY 20252025-01-31 · USD | FY 20242024-01-31 · USD | FY 20232023-01-31 · USD | FY 20222022-01-31 · USD | FY 20212021-01-31 · USD | FY 20202020-01-31 · USD | FY 20192019-01-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 5,173,425,000USD | 5,194,430,000USD | 5,363,152,000USD | 6,612,829,000USD | 6,497,941,000USD | 6,075,702,000USD | 6,155,118,000USD | 4,924,379,000USD |
| Intangible Assets | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,025,000,000USD | 1,028,106,000USD | 1,172,006,000USD |
| Other Current Assets | 127,028,000USD | 114,109,000USD | 97,445,000USD | 112,083,000USD | 128,446,000USD | 85,645,000USD | 51,736,000USD | 82,936,000USD |
| Total Liab | 4,009,171,000USD | 4,080,800,000USD | 4,178,723,000USD | 4,231,352,000USD | 4,242,122,000USD | 4,020,437,000USD | 5,594,057,000USD | 4,286,470,000USD |
| Total Stockholder Equity | 1,164,254,000USD | 1,113,630,000USD | 1,184,429,000USD | 2,381,477,000USD | 2,274,014,000USD | 2,068,848,000USD | 569,391,000USD | 637,909,000USD |
| Other Current Liab | 358,899,000USD | 237,706,000USD | 201,974,000USD | 235,005,000USD | 296,887,000USD | 212,785,000USD | 189,753,000USD | 187,537,000USD |
| Common Stock | 282,000USD | 277,000USD | 269,000USD | 266,000USD | 265,000USD | 264,000USD | 1,358,130,000USD | 1,347,622,000USD |
| Capital Stock | 282,000USD | 277,000USD | 269,000USD | 266,000USD | 265,000USD | 264,000USD | 1,358,130,000USD | 1,347,622,000USD |
| Retained Earnings | -1,139,993,000USD | -1,149,059,000USD | -1,047,243,000USD | 232,967,000USD | 142,166,000USD | -22,251,000USD | -780,466,000USD | -707,518,000USD |
| Good Will | 980,064,000USD | 980,064,000USD | 980,297,000USD | 2,193,941,000USD | 2,183,991,000USD | 2,179,310,000USD | 2,179,310,000USD | 2,176,290,000USD |
| Cash | 256,736,000USD | 165,756,000USD | 125,428,000USD | 201,901,000USD | 211,602,000USD | 111,402,000USD | 148,785,000USD | 180,649,000USD |
| Cash And Short Term Investments | 256,736,000USD | 165,756,000USD | 125,428,000USD | 201,901,000USD | 211,602,000USD | 111,402,000USD | 148,785,000USD | 180,649,000USD |
| Total Current Assets | 1,019,786,000USD | 973,619,000USD | 951,744,000USD | 1,015,994,000USD | 1,070,777,000USD | 777,549,000USD | 711,005,000USD | 761,608,000USD |
| Total Current Liabilities | 1,134,141,000USD | 1,139,163,000USD | 1,113,143,000USD | 1,021,258,000USD | 1,053,139,000USD | 875,307,000USD | 841,941,000USD | 543,470,000USD |
| Net Debt | 2,603,666,000USD | 2,793,041,000USD | 2,918,051,000USD | 2,930,787,000USD | 2,837,634,000USD | 2,890,382,000USD | 4,543,276,000USD | 3,045,124,000USD |
| Short Term Debt | 324,690,000USD | 335,053,000USD | 342,431,000USD | 332,560,000USD | 287,661,000USD | 260,492,000USD | 306,872,000USD | 28,354,000USD |
| Short Long Term Debt Total | 2,860,402,000USD | 2,958,797,000USD | 3,043,479,000USD | 3,132,688,000USD | 3,049,236,000USD | 3,001,784,000USD | 4,692,061,000USD | 3,225,773,000USD |
| Long Term Debt | 1,488,527,000USD | 1,578,091,000USD | 1,576,223,000USD | 1,628,331,000USD | 1,640,390,000USD | 1,646,281,000USD | 3,228,447,000USD | 3,197,419,000USD |
| Net Receivables | 45,812,000USD | 40,425,000USD | 44,369,000USD | 49,580,000USD | 55,618,000USD | 41,827,000USD | 31,516,000USD | 27,879,000USD |
| Inventory | 590,210,000USD | 653,329,000USD | 684,502,000USD | 652,430,000USD | 675,111,000USD | 538,675,000USD | 478,968,000USD | 470,144,000USD |
| Accounts Payable | 450,552,000USD | 492,878,000USD | 485,131,000USD | 381,213,000USD | 403,976,000USD | 339,485,000USD | 293,203,000USD | 276,932,000USD |
| Property Plant Equipment Net | 1,944,741,000USD | 2,027,784,000USD | 2,200,417,000USD | 2,201,088,000USD | 2,065,387,000USD | 1,955,655,000USD | 2,115,860,000USD | 683,547,000USD |
| Property Plant Equipment Gross | 3,666,801,000USD | 3,568,261,000USD | 3,557,065,000USD | 2,201,088,000USD | 2,065,387,000USD | 1,955,655,000USD | 2,115,860,000USD | 683,547,000USD |
| Accumulated Other Comprehensive Income | -8,389,000USD | -18,083,000USD | 1,821,000USD | -4,098,000USD | -2,238,000USD | -1,275,000USD | -8,273,000USD | -2,195,000USD |
| Common Stock Shares Outstanding | 286,148,000shares | 273,410,000shares | 267,548,999shares | 265,951,000shares | 265,338,000shares | 210,683,000shares | 1,458,558,036shares | 1,457,412,000shares |
| Non Current Assets Total | 4,153,639,000USD | 4,220,811,000USD | 4,411,408,000USD | 5,596,835,000USD | 5,427,164,000USD | 5,298,153,000USD | 5,445,666,000USD | 4,162,771,000USD |
| Non Current Liabilities Total | 2,875,030,000USD | 2,941,637,000USD | 3,065,580,000USD | 3,210,094,000USD | 3,188,983,000USD | 3,145,130,000USD | 4,752,116,000USD | 3,743,000,000USD |
| Non Current Liabilities Other | 51,052,000USD | 49,378,000USD | 57,423,000USD | 1,278,642,000USD | 134,105,000USD | 134,354,000USD | 41,629,000USD | 116,726,000USD |
| Non Currrent Assets Other | 203,834,000USD | 174,017,000USD | 205,694,000USD | 176,806,000USD | 152,786,000USD | 138,188,000USD | 122,390,000USD | 130,928,000USD |
| Net Working Capital | -114,355,000USD | -165,544,000USD | -161,399,000USD | -5,264,000USD | 17,638,000USD | -97,758,000USD | -130,936,000USD | 218,138,000USD |
| Unclassified Non Current Liabilities | 1,335,451,000USD | 1,314,168,000USD | 1,431,934,000USD | -409,966,000USD | 643,673,000USD | 960,657,000USD | 1,128,154,000USD | -116,726,000USD |
| Unclassified Equity | 2,312,072,000USD | 2,280,218,000USD | 2,229,313,000USD | 2,152,076,000USD | 2,133,556,000USD | 2,091,846,000USD | -1,358,130,000USD | -1,347,622,000USD |
| Current Deferred Revenue | — | 29,564,000USD | 33,523,000USD | 23,045,000USD | 18,003,000USD | 15,526,000USD | 46,412,000USD | — |
| Unclassified Current Liabilities | — | 43,962,000USD | 34,122,000USD | 26,641,000USD | 24,848,000USD | 44,816,000USD | -22,942,000USD | 22,293,000USD |
| Short Long Term Debt | — | — | 15,962,000USD | 22,794,000USD | 21,764,000USD | 2,203,000USD | 28,643,000USD | 28,354,000USD |
| Short Term Investments | — | — | 2,259,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 303,121,000USD | 318,355,000USD | — | — | — |
| Other Liab | — | — | — | 409,966,000USD | 452,460,000USD | 403,838,000USD | 353,886,000USD | 545,581,000USD |
| Other Assets | — | — | — | 176,806,000USD | 152,786,000USD | -714,000USD | -1,553,000USD | 130,928,000USD |
| Net Tangible Assets | — | — | — | -837,464,000USD | -934,977,000USD | -1,136,176,000USD | -2,636,472,000USD | -2,710,387,000USD |
| Unclassified Non Current Assets | — | — | — | -176,806,000USD | -152,786,000USD | — | — | -130,928,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-08-01 · USD |
|---|---|
| Depreciation | 99,440,000USD |
| Stock Based Compensation | 18,051,000USD |
| Deferred Income Tax | -1,439,000USD |
| Other Non Cash Items | -11,840,000USD |
| Change To Account Receivables | 7,427,000USD |
| Change To Inventory | -11,381,000USD |
| Change To Liabilities | 12,191,000USD |
| Change In Working Capital | -16,802,000USD |
| Operating Cash Flow | 130,584,000USD |
| Capital Expenditures | -69,788,000USD |
| Other Investing Activities | 0USD |
| Unclassified Investing Cash Flow | 496,000USD |
| Investing Cash Flow | -69,292,000USD |
| Net Debt Issuance | -5,422,000USD |
| Net Common Stock Issuance | -4,261,000USD |
| Unclassified Financing Cash Flow | -26,519,000USD |
| Financing Cash Flow | -36,202,000USD |
| Change In Cash | 25,090,000USD |
| End Cash Flow | 294,502,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q2 20262026-07-31 · USD | Q4 20262026-01-31 · USD | Q3 20262025-10-31 · USD | Q1 20262025-04-30 · USD | Q4 20252025-01-31 · USD | Q3 20252024-10-31 · USD | Q2 20252024-07-31 · USD | Q1 20252024-04-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 38,660,000USD | 6,755,000USD | 9,330,000USD | -11,661,000USD | -13,837,000USD | -16,673,000USD | -24,823,000USD | -46,483,000USD |
| Depreciation | 1,803,480,000USD | 98,061,000USD | 49,817,000USD | 49,365,000USD | 50,313,000USD | 50,109,000USD | 49,718,000USD | 49,587,000USD |
| Operating Cash Flow | 130,584,000USD | — | — | — | — | — | — | — |
| Investing Cash Flow | -69,292,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | -36,202,000USD | — | — | — | — | — | — | — |
| Change In Cash | 25,090,000USD | 79,680,000USD | 47,681,000USD | -42,921,000USD | 60,644,000USD | -12,625,000USD | 42,782,000USD | -45,785,000USD |
| End Cash Flow | 294,502,000USD | — | — | — | — | — | — | — |
| Stock Based Compensation | — | 14,441,000USD | 7,163,000USD | 9,420,000USD | 9,507,000USD | 11,357,000USD | 11,914,000USD | 17,434,000USD |
| Other Non Cash Items | — | 113,602,000USD | 98,526,000USD | 89,784,000USD | 105,539,000USD | 84,795,000USD | 88,993,000USD | 91,648,000USD |
| Change To Account Receivables | — | -2,912,000USD | -8,492,000USD | 4,229,000USD | -109,000USD | 6,370,000USD | -5,070,000USD | 2,987,000USD |
| Change To Inventory | — | 27,686,000USD | -9,390,000USD | 7,857,000USD | 36,961,000USD | -17,963,000USD | 8,693,000USD | 3,076,000USD |
| Change In Working Capital | — | -14,402,000USD | -74,746,000USD | -152,362,000USD | -55,529,000USD | -108,864,000USD | -56,432,000USD | -120,600,000USD |
| Total Cash From Operating Activities | — | 243,612,000USD | 90,090,000USD | -15,454,000USD | 95,993,000USD | 20,724,000USD | 69,370,000USD | -8,414,000USD |
| Capital Expenditures | — | -28,412,000USD | -29,444,000USD | -28,412,000USD | -36,949,000USD | -31,012,000USD | -27,388,000USD | -32,641,000USD |
| Free Cash Flow | — | 215,200,000USD | 60,646,000USD | -43,866,000USD | 59,044,000USD | -10,288,000USD | 41,982,000USD | -41,055,000USD |
| Investments | — | 0USD | 0USD | -27,133,000USD | -34,397,000USD | -31,441,000USD | -26,322,000USD | -31,743,000USD |
| Total Cashflows From Investing Activities | — | -66,465,000USD | -29,328,000USD | -27,133,000USD | -34,397,000USD | -31,441,000USD | -26,322,000USD | -31,743,000USD |
| Net Borrowings | — | -96,431,000USD | -1,181,000USD | -1,143,000USD | -1,099,000USD | -1,080,000USD | -2,084,000USD | — |
| Total Cash From Financing Activities | — | -97,467,000USD | -1,071,000USD | -334,000USD | -952,000USD | -1,908,000USD | -266,000USD | -5,628,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | — | 0USD | 0USD | — | — |
| Begin Period Cash Flow | — | 189,732,000USD | 189,732,000USD | 181,665,000USD | 121,021,000USD | 133,646,000USD | 90,864,000USD | 136,649,000USD |
| End Period Cash Flow | — | 269,412,000USD | 237,413,000USD | 138,744,000USD | 181,665,000USD | 121,021,000USD | 133,646,000USD | 90,864,000USD |
| Other Cashflows From Investing Activities | — | -38,053,000USD | — | 1,279,000USD | 2,717,000USD | -224,000USD | 1,225,000USD | 998,000USD |
| Other Cashflows From Financing Activities | — | -7,589,000USD | -5,063,000USD | -158,000USD | 147,000USD | -828,000USD | 1,818,000USD | -4,184,000USD |
| Unclassified Operating Cash Flow | — | 25,155,000USD | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 6,553,000USD | 5,173,000USD | — | — | — | 1,409,000USD | — |
| Unclassified Investing Cash Flow | — | — | — | 27,133,000USD | 34,232,000USD | 31,236,000USD | 26,163,000USD | 31,643,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | -1,409,000USD | -2,059,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-01-31 · USD | FY 20252025-01-31 · USD | FY 20242024-01-31 · USD | FY 20232023-01-31 · USD | FY 20222022-01-31 · USD | FY 20212021-01-31 · USD | FY 20202020-01-31 · USD | FY 20192019-01-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 9,066,000USD | -101,816,000USD | -1,280,210,000USD | 89,910,000USD | 159,805,000USD | -31,736,000USD | -103,984,000USD | -413,788,000USD |
| Depreciation | 196,710,000USD | 199,727,000USD | 200,782,000USD | 193,828,000USD | 172,431,000USD | 174,836,000USD | 173,544,000USD | 186,997,000USD |
| Stock Based Compensation | 32,650,000USD | 50,212,000USD | 81,859,000USD | 60,784,000USD | 49,265,000USD | 12,915,000USD | 9,489,000USD | 8,452,000USD |
| Other Non Cash Items | 396,485,000USD | 370,975,000USD | 1,585,353,000USD | 428,690,000USD | 452,378,000USD | 464,991,000USD | 452,468,000USD | 364,911,000USD |
| Change To Account Receivables | -5,621,000USD | 4,178,000USD | 5,211,000USD | 6,038,000USD | -13,791,000USD | -424,575,000USD | -3,845,000USD | 23,630,000USD |
| Change To Inventory | 63,119,000USD | 30,767,000USD | -32,072,000USD | 22,681,000USD | -136,404,000USD | -60,635,000USD | -8,193,000USD | 644,000USD |
| Change In Working Capital | -337,911,000USD | -341,425,000USD | -372,065,000USD | -427,209,000USD | -475,664,000USD | -404,612,000USD | -421,180,000USD | 56,630,000USD |
| Total Cash From Operating Activities | 314,050,000USD | 177,673,000USD | 215,719,000USD | 346,003,000USD | 358,215,000USD | 268,615,000USD | 110,337,000USD | 203,202,000USD |
| Capital Expenditures | -127,097,000USD | -127,990,000USD | -225,598,000USD | -278,020,000USD | -239,110,000USD | -159,560,000USD | -157,356,000USD | -148,363,000USD |
| Free Cash Flow | 186,953,000USD | 49,683,000USD | -9,879,000USD | 67,983,000USD | 119,105,000USD | 109,055,000USD | -47,019,000USD | 54,839,000USD |
| Investments | 0USD | -123,903,000USD | -207,445,000USD | -35,000,000USD | 6,135,000USD | -927,000USD | -139,041,000USD | -767,000USD |
| Total Cashflows From Investing Activities | -124,556,000USD | -123,903,000USD | -207,445,000USD | -320,324,000USD | -237,083,000USD | -157,185,000USD | -139,041,000USD | -142,682,000USD |
| Net Borrowings | -100,864,000USD | -5,707,000USD | -80,925,000USD | -17,000,000USD | 5,575,000USD | -1,082,294,000USD | -506,000USD | -28,140,000USD |
| Total Cash From Financing Activities | -101,747,000USD | -8,754,000USD | -85,352,000USD | -33,842,000USD | -18,782,000USD | -146,608,000USD | -3,071,000USD | -32,099,000USD |
| Issuance Of Capital Stock | 0USD | 2,500,000USD | 0USD | 0USD | 0USD | 936,041,000USD | 0USD | 0USD |
| Change In Cash | 87,747,000USD | 45,016,000USD | -77,078,000USD | -8,163,000USD | 102,350,000USD | -35,178,000USD | -31,775,000USD | 28,421,000USD |
| Begin Period Cash Flow | 181,665,000USD | 136,649,000USD | 213,727,000USD | 221,890,000USD | 119,540,000USD | 154,718,000USD | 186,493,000USD | 158,072,000USD |
| End Period Cash Flow | 269,412,000USD | 181,665,000USD | 136,649,000USD | 213,727,000USD | 221,890,000USD | 119,540,000USD | 154,718,000USD | 186,493,000USD |
| Other Cashflows From Investing Activities | -124,556,000USD | 4,175,000USD | — | 2,336,000USD | 226,000USD | 3,302,000USD | 20,058,000USD | 6,148,000USD |
| Other Cashflows From Financing Activities | -10,174,000USD | -5,547,000USD | -4,427,000USD | -11,759,000USD | -24,357,000USD | 951,750,000USD | -3,374,000USD | -3,848,000USD |
| Unclassified Operating Cash Flow | 17,050,000USD | — | — | — | — | 52,221,000USD | — | — |
| Unclassified Investing Cash Flow | 127,097,000USD | 123,815,000USD | 225,598,000USD | -9,640,000USD | -4,334,000USD | — | 137,298,000USD | — |
| Unclassified Financing Cash Flow | 9,291,000USD | 8,789,000USD | 8,650,000USD | 22,231,000USD | — | 460,041,000USD | — | — |
| Sale Purchase Of Stock | — | -6,289,000USD | -8,650,000USD | -15,555,000USD | -33,000USD | -105,000USD | 0USD | -111,000USD |
| Change To Liabilities | — | — | — | -63,736,000USD | 71,775,000USD | 46,303,000USD | 15,928,000USD | 23,771,000USD |
| Dividends Paid | — | — | — | -11,759,000USD | -308,000USD | -476,000,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -8,163,000USD | 102,350,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2026Yearly · 2026-01-31 | Product | Consumables | 2,968,321,000 | USD | 0001193125-26-106114 |
| FY 2026Yearly · 2026-01-31 | Product | Services And Other | 1,025,144,000 | USD | 0001193125-26-106114 |
| FY 2026Yearly · 2026-01-31 | Product | Supplies And Companion Animals | 1,968,002,000 | USD | 0001193125-26-106114 |
| Q3 2026Quarterly · 2025-10-31 | Product | Consumables | 731,456,000 | USD | 0001193125-25-309620 |
| Q3 2026Quarterly · 2025-10-31 | Product | Services And Other | 254,810,000 | USD | 0001193125-25-309620 |
| Q3 2026Quarterly · 2025-10-31 | Product | Supplies And Companion Animals | 478,145,000 | USD | 0001193125-25-309620 |
| Q1 2026Quarterly · 2025-04-30 | Product | Consumables | 748,070,000 | USD | 0001193125-26-259944 |
| Q1 2026Quarterly · 2025-04-30 | Product | Services And Other | 251,508,000 | USD | 0001193125-26-259944 |
| Q1 2026Quarterly · 2025-04-30 | Product | Supplies And Companion Animals | 493,821,000 | USD | 0001193125-26-259944 |
| FY 2025Yearly · 2025-01-31 | Product | Consumables | 3,043,178,000 | USD | 0001193125-26-106114 |
| FY 2025Yearly · 2025-01-31 | Product | Services And Other | 999,571,000 | USD | 0001193125-26-106114 |
| FY 2025Yearly · 2025-01-31 | Product | Supplies And Companion Animals | 2,073,713,000 | USD | 0001193125-26-106114 |
| Q4 2025Quarterly · 2025-01-31 | Product | Consumables | 781,208,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-01-31 | Product | Services And Other | 241,913,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-01-31 | Product | Supplies And Companion Animals | 529,009,000 | USD | Legacy provider |
| Q3 2025Quarterly · 2024-10-31 | Product | Consumables | 753,230,000 | USD | 0001193125-25-309620 |
| Q3 2025Quarterly · 2024-10-31 | Product | Services And Other | 248,243,000 | USD | 0001193125-25-309620 |
| Q3 2025Quarterly · 2024-10-31 | Product | Supplies And Companion Animals | 509,964,000 | USD | 0001193125-25-309620 |
| Q2 2025Quarterly · 2024-07-31 | Product | Consumables | 744,766,000 | USD | 0001826470-25-000015 |
| Q2 2025Quarterly · 2024-07-31 | Product | Services And Other | 260,006,000 | USD | 0001826470-25-000015 |
| Q2 2025Quarterly · 2024-07-31 | Product | Supplies And Companion Animals | 518,983,000 | USD | 0001826470-25-000015 |
| Q1 2025Quarterly · 2024-04-30 | Product | Consumables | 763,974,000 | USD | 0000950170-25-083057 |
| Q1 2025Quarterly · 2024-04-30 | Product | Services And Other | 249,409,000 | USD | 0000950170-25-083057 |
| Q1 2025Quarterly · 2024-04-30 | Product | Supplies And Companion Animals | 515,757,000 | USD | 0000950170-25-083057 |
| FY 2024Yearly · 2024-01-31 | Product | Consumables | 3,063,845,000 | USD | 0001193125-26-106114 |
| FY 2024Yearly · 2024-01-31 | Product | Services And Other | 981,574,000 | USD | 0001193125-26-106114 |
| FY 2024Yearly · 2024-01-31 | Product | Supplies And Companion Animals | 2,209,865,000 | USD | 0001193125-26-106114 |
| Q4 2024Quarterly · 2024-01-31 | Product | Consumables | 833,440,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-01-31 | Product | Services And Other | 253,763,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-01-31 | Product | Supplies And Companion Animals | 587,273,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2023-10-31 | Product | Consumables | 733,277,000 | USD | 0000950170-24-134077 |
| Q3 2024Quarterly · 2023-10-31 | Product | Services And Other | 236,363,000 | USD | 0000950170-24-134077 |
| Q3 2024Quarterly · 2023-10-31 | Product | Supplies And Companion Animals | 524,526,000 | USD | 0000950170-24-134077 |
| FY 2023Yearly · 2023-01-31 | Product | Consumables | 2,859,602,000 | USD | 0000950170-25-047693 |
| FY 2023Yearly · 2023-01-31 | Product | Services And Other | 805,452,000 | USD | 0000950170-25-047693 |
| FY 2023Yearly · 2023-01-31 | Product | Supplies And Companion Animals | 2,370,913,000 | USD | 0000950170-25-047693 |
| FY 2022Yearly · 2022-01-31 | Product | Consumables | 2,533,755,000 | USD | 0000950170-24-040516 |
| FY 2022Yearly · 2022-01-31 | Product | Services And Other | 670,290,000 | USD | 0000950170-24-040516 |
| FY 2022Yearly · 2022-01-31 | Product | Supplies And Companion Animals | 2,603,104,000 | USD | 0000950170-24-040516 |
| FY 2021Yearly · 2021-01-31 | Product | Consumables | 2,123,499,000 | USD | 0000950170-23-010285 |
| FY 2021Yearly · 2021-01-31 | Product | Services And Other | 468,040,000 | USD | 0000950170-23-010285 |
| FY 2021Yearly · 2021-01-31 | Product | Supplies And Companion Animals | 2,328,663,000 | USD | 0000950170-23-010285 |
| FY 2020Yearly · 2020-01-31 | Product | Consumables | 2,054,280,000 | USD | 0001564590-22-011685 |
| FY 2020Yearly · 2020-01-31 | Product | Services And Other | 441,330,000 | USD | 0001564590-22-011685 |
| FY 2020Yearly · 2020-01-31 | Product | Supplies And Companion Animals | 1,938,904,000 | USD | 0001564590-22-011685 |
| FY 2011Yearly · 2011-12-31 | Segment | All Other Segments | 62,773,000 | USD | 0001193125-12-088954 |
| FY 2011Yearly · 2011-12-31 | Segment | Animal Hospital | 1,150,120,000 | USD | 0001193125-12-088954 |
| FY 2011Yearly · 2011-12-31 | Segment | Laboratory | 272,468,000 | USD | 0001193125-12-088954 |
| Q3 2011Quarterly · 2011-09-30 | Segment | Animal Hospital | 303,203,000 | USD | 0001193125-11-302741 |
| Q3 2011Quarterly · 2011-09-30 | Segment | Laboratory | 67,588,000 | USD | 0001193125-11-302741 |
| Q3 2011Quarterly · 2011-09-30 | Segment | Other Segments | 14,344,000 | USD | 0001193125-11-302741 |
| Q2 2011Quarterly · 2011-06-30 | Segment | Animal Hospital | 291,332,000 | USD | 0000950123-11-073554 |
| Q2 2011Quarterly · 2011-06-30 | Segment | Laboratory | 72,955,000 | USD | 0000950123-11-073554 |
| Q2 2011Quarterly · 2011-06-30 | Segment | Medical Technology | 11,818,000 | USD | 0000950123-11-073554 |
| FY 2010Yearly · 2010-12-31 | Segment | All Other Segments | 55,390,000 | USD | 0001193125-12-088954 |
| FY 2010Yearly · 2010-12-31 | Segment | Animal Hospital | 1,052,462,000 | USD | 0001193125-12-088954 |
| FY 2010Yearly · 2010-12-31 | Segment | Laboratory | 273,616,000 | USD | 0001193125-12-088954 |
| Q3 2010Quarterly · 2010-09-30 | Segment | Animal Hospital | 276,739,000 | USD | 0001193125-11-302741 |
| Q3 2010Quarterly · 2010-09-30 | Segment | Laboratory | 67,872,000 | USD | 0001193125-11-302741 |
| Q3 2010Quarterly · 2010-09-30 | Segment | Other Segments | 14,092,000 | USD | 0001193125-11-302741 |
| Q2 2010Quarterly · 2010-06-30 | Segment | Animal Hospital | 267,595,000 | USD | 0000950123-11-073554 |
| Q2 2010Quarterly · 2010-06-30 | Segment | Laboratory | 73,259,000 | USD | 0000950123-11-073554 |
| Q2 2010Quarterly · 2010-06-30 | Segment | Medical Technology | 13,065,000 | USD | 0000950123-11-073554 |
| FY 2009Yearly · 2009-12-31 | Segment | All Other Segments | 42,764,000 | USD | 0001193125-12-088954 |
| FY 2009Yearly · 2009-12-31 | Segment | Animal Hospital | 994,215,000 | USD | 0001193125-12-088954 |
| FY 2009Yearly · 2009-12-31 | Segment | Laboratory | 277,528,000 | USD | 0001193125-12-088954 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.